R V Lloyd
Overview
Explore the profile of R V Lloyd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
311
Citations
4714
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vidal S, Kovacs K, Cohen S, Stefaneanu L, Lloyd R, Scheithauer B
Endocr Pathol
. 2016 Aug;
10(2):109-22.
PMID: 27519215
Vascular endothelial growth factor (VEGF) is a key mediator of endothelial cell proliferation, angiogenesis, and vascular permeability. Our aim was to investigate whether VEGF is expressed in various cell types...
2.
Jia H, Francois F, Bourien J, Eybalin M, Lloyd R, Van De Water T, et al.
Neuroscience
. 2016 Jan;
316:261-78.
PMID: 26718602
Cochlear fibrosis is a common finding following cochlear implantation. Evidence suggests that cochlear fibrosis could be triggered by inflammation and epithelial-to-mesenchymal cell transition (EMT). In this study, we investigate the...
3.
Starenki D, Hong S, Lloyd R, Park J
Oncogene
. 2014 Dec;
34(35):4624-34.
PMID: 25435367
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor mainly caused by mutations in the rearranged during transfection (RET) proto-oncogene. For therapy of advanced MTC, the Food and Drug Administration recently...
4.
Scheithauer B, Horvath E, Abel T, Robital Y, Park S, Osamura R, et al.
Pituitary
. 2011 Aug;
15(3):365-73.
PMID: 21805093
Pituitary blastoma, a recently described tumor of the neonatal pituitary, exhibits differentiation to Rathke epithelium and adenohypophysial cells of folliculostellate and secretory type, a reflection of arrested pituitary development and...
5.
Righi A, Jin L, Zhang S, Stilling G, Scheithauer B, Kovacs K, et al.
Mol Cell Endocrinol
. 2010 May;
326(1-2):8-14.
PMID: 20451577
Although the mechanisms regulating pituitary tumor development and progression are still unclear, new information on the molecular mechanisms involved in the pathogenesis of human pituitary tumors have accumulated. Recent evidence...
6.
Roncaroli F, Scheithauer B, Horvath E, Erickson D, Tam C, Lloyd R, et al.
Neuropathol Appl Neurobiol
. 2009 Oct;
36(1):90-4.
PMID: 19811617
No abstract available.
7.
Al-Shraim M, Al-Sharim M, Scheithauer B, Horvath E, Kovacs K, Smyth H, et al.
Clin Neuropathol
. 2009 Jun;
28(3):182-7.
PMID: 19537135
Objective And Importance: Pituitary adenomas producing primarily FSH and to a lesser extent GH, LH, alpha-subunit, TSH and PRL without clinical or laboratory evidence of increased hormone release have not...
8.
McLaren R, Gibbins N, Varia M, Lloyd R, Shotton J
Clin Otolaryngol
. 2009 May;
34(2):166-7.
PMID: 19413621
No abstract available.
9.
Erickson D, Scheithauer B, Atkinson J, Horvath E, Kovacs K, Lloyd R, et al.
Clin Endocrinol (Oxf)
. 2009 Jan;
71(1):92-9.
PMID: 19170710
Background: Macroadenomas represent 50% of pituitary tumours and are often (30%) nonfunctioning. Their immunophenotype suggests differentiation toward a specific pituitary cell line. A substantial proportion of tumours with particularly aggressive...
10.
Lombardero M, Kovacs K, Horvath E, Scheithauer B, Rotondo F, Salehi F, et al.
Histol Histopathol
. 2007 Oct;
23(1):11-7.
PMID: 17952853
Adrenomedullin (ADM) is a novel peptide originally identified in extracts of human pheochromocytoma. It is produced by several tissues, including the pituitary gland. The presence of ADM has been immunohistochemically...